Organogenesis Holdings Inc. ORGO Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept orgo:AccruedExpensesAndOtherCurrentLiabilities.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s accrued expenses and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s accrued expenses and other current liabilities?
- Organogenesis Holdings Inc. (ORGO) reported accrued expenses and other current liabilities of $37.68M in Q1 2026.
- How has Organogenesis Holdings Inc.'s accrued expenses and other current liabilities changed year-over-year?
- Organogenesis Holdings Inc.'s accrued expenses and other current liabilities increased by 21.0% year-over-year, from $31.14M to $37.68M.
- What is the long-term trend for Organogenesis Holdings Inc.'s accrued expenses and other current liabilities?
- Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s accrued expenses and other current liabilities has grown at a 15.6% compound annual growth rate (CAGR), from $23.97M to $49.53M.
- What does accrued expenses and other current liabilities mean?
- This encompasses short-term obligations for goods or services received but not yet invoiced or paid, including items like employee compensation, professional fees, and other operational costs. It serves as a measure of the company's immediate operational liabilities that will require cash settlement in the near term. A stable or predictable trend in these accruals is essential for accurate working capital management.